2021
Incidence and associated risk factors for invasive fungal infections and other serious infections in patients on ibrutinib
Holowka T, Cheung H, Malinis M, Gan G, Deng Y, Perreault S, Isufi I, Azar MM. Incidence and associated risk factors for invasive fungal infections and other serious infections in patients on ibrutinib. Journal Of Infection And Chemotherapy 2021, 27: 1700-1705. PMID: 34389223, DOI: 10.1016/j.jiac.2021.08.005.Peer-Reviewed Original ResearchConceptsInvasive fungal infectionsSerious infectionsRisk factorsHematologic malignanciesAdvanced ageMultivariate analysis risk factorsSmall molecule tyrosine kinase inhibitorsSingle tertiary care centerFungal infectionsConcurrent useCytotoxic agentsMolecule tyrosine kinase inhibitorsAnalysis risk factorsTertiary care centerTyrosine kinase inhibitorsElectronic medical recordsResult of infectionMost patientsClinical featuresInfected patientsMedical recordsCare centerImmune effectorsPatientsViral infection
2020
Orally Administered Human Immunoglobulin Therapy for Norovirus Enteritis in Solid Organ Transplant Recipients: A Case Series at a Single Academic Transplant Center
Nussbaum EZ, Azar M, Cohen E, McManus D, Topal J, Malinis M. Orally Administered Human Immunoglobulin Therapy for Norovirus Enteritis in Solid Organ Transplant Recipients: A Case Series at a Single Academic Transplant Center. Clinical Infectious Diseases 2020, 71: e206-e209. PMID: 31999825, DOI: 10.1093/cid/ciaa093.Peer-Reviewed Original ResearchConceptsSolid organ transplant recipientsOrgan transplant recipientsNorovirus enteritisTransplant recipientsAcademic transplant centersHuman immunoglobulin therapyEffective treatment modalityImmunoglobulin therapySOT recipientsCase seriesTransplant centersIntractable diarrheaTreatment modalitiesMedical recordsHuman immunoglobulinEnteritisRecipientsDiarrheaTherapyImmunoglobulin